KD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Kyndryl Holdings Inc (KD) is not a good buy for a beginner investor with a long-term strategy. The company is facing significant challenges, including management instability, delayed filings, financial misstatements, and weak analyst sentiment. The technical indicators are bearish, and there are no strong positive catalysts to offset the negative sentiment and risks. Given the investor's background and goals, this stock is better avoided at this time.
The technical indicators for KD are bearish. The MACD histogram is -1.37, indicating a negative trend. The RSI_6 is at 20.439, which is in the neutral zone but leaning towards oversold territory. The moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. Key support levels are at S1: 12.157 and S2: 8.935, while resistance levels are far above the current price, indicating limited upside potential.
Kyndryl has announced a partnership with Yamaguchi Financial Group to develop an integrated core banking system, which could enhance operational efficiency in the long term.
The company is facing multiple lawsuits alleging financial misstatements and inadequate internal controls. Recent management departures, including the CFO, have raised concerns about stability. Analysts have downgraded the stock significantly, citing weak guidance, extended sales cycles, and material weaknesses in internal controls. The stock has plummeted over 55% recently, reflecting a loss of investor confidence.
In Q3 2026, revenue increased by 3.07% YoY to $3.859 billion. However, net income dropped by 73.49% YoY to $57 million, and EPS fell by 71.91% YoY to $0.25. While gross margin improved to 21.85% (up 7.21% YoY), the overall financial performance indicates significant profitability challenges.
Analyst sentiment is overwhelmingly negative. JPMorgan downgraded the stock to Underweight with a price target of $16, down from $40, citing weak guidance and management instability. Guggenheim and Oppenheimer also downgraded the stock, removing price targets and highlighting extended sales cycles and internal control issues. The consensus view is that the company faces significant uncertainty and risks.
